Related Content
Search Google Scholar for:
|
|
Science 8 April 1994: Vol. 264. no. 5156, pp. 276 - 279 DOI: 10.1126/science.8146663
|
|
Articles
Science, Vol 264, Issue 5156, 276-279
Copyright © 1994 by American Association for the Advancement of Science
Soluble beta-amyloid induction of Alzheimer's phenotype for human fibroblast K+ channels
R Etcheberrigaray,
E Ito,
CS Kim,
and
DL Alkon
Laboratory of Adaptive Systems, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20892.
Although beta-amyloid is the main constituent of neurite plaques and may play a role in the pathophysiology of Alzheimer's disease, mechanisms by which soluble beta-amyloid might produce early symptoms such as memory loss before diffuse plaque deposition have not been implicated. Treatment of fibroblasts with beta-amyloid (10 nM) induced the same potassium channel dysfunction previously shown to occur specifically in fibroblasts from patients with Alzheimer's disease--namely, the absence of a 113-picosiemen potassium channel. A tetraethylammonium-induced increase of intracellular concentrations of calcium, [Ca2+]i, a response that depends on functional 113-picosiemen potassium channels, was also eliminated or markedly reduced by 10 nM beta-amyloid. Increased [Ca2+]i induced by high concentrations of extracellular potassium and 166-picosiemen potassium channels were unaffected by 10 nM beta-amyloid. In Alzheimer's disease, then, beta-amyloid might alter potassium channels and thus impair neuronal function to produce symptoms such as memory loss by a means other than plaque formation.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
- Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil.
- B. Sharma, N. Singh, and M. Singh (2008)
J Psychopharmacol
22, 162-171
| Abstract »
| PDF »
- Protection against beta-Amyloid-induced Apoptosis by Peptides Interacting with beta-Amyloid.
- T. J. Nelson and D. L. Alkon (2007)
J. Biol. Chem.
282, 31238-31249
| Abstract »
| Full Text »
| PDF »
- An internally controlled peripheral biomarker for Alzheimer's disease: Erk1 and Erk2 responses to the inflammatory signal bradykinin.
- T. K. Khan and D. L. Alkon (2006)
PNAS
103, 13203-13207
| Abstract »
| Full Text »
| PDF »
- Amyloid ion channels: A common structural link for protein-misfolding disease.
- A. Quist, I. Doudevski, H. Lin, R. Azimova, D. Ng, B. Frangione, B. Kagan, J. Ghiso, and R. Lal (2005)
PNAS
102, 10427-10432
| Abstract »
| Full Text »
| PDF »
- Oxidation of Cholesterol by Amyloid Precursor Protein and {beta}-Amyloid Peptide.
- T. J. Nelson and D. L. Alkon (2005)
J. Biol. Chem.
280, 7377-7387
| Abstract »
| Full Text »
| PDF »
- Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice.
- R. Etcheberrigaray, M. Tan, I. Dewachter, C. Kuiperi, I. Van der Auwera, S. Wera, L. Qiao, B. Bank, T. J. Nelson, A. P. Kozikowski, et al. (2004)
PNAS
101, 11141-11146
| Abstract »
| Full Text »
| PDF »
- Impairment of Hippocampal CA1 Heterosynaptic Transformation and Spatial Memory by beta -Amyloid25-35.
- M.-K. Sun and D. L. Alkon (2002)
J Neurophysiol
87, 2441-2449
| Abstract »
| Full Text »
| PDF »
- Amyloid {beta} protein forms ion channels: implications for Alzheimer's disease pathophysiology.
- H. LIN, R. BHATIA, and R. LAL (2001)
FASEB J
15, 2433-2444
| Abstract »
| Full Text »
| PDF »
- Potassium Channels: Molecular Defects, Diseases, and Therapeutic Opportunities.
- C.-C. Shieh, M. Coghlan, J. P. Sullivan, and M. Gopalakrishnan (2000)
Pharmacol. Rev.
52, 557-594
| Abstract »
| Full Text »
| PDF »
- Fresh and globular amyloid {beta} protein (1-42) induces rapid cellular degeneration: evidence for A{beta}P channel-mediated cellular toxicity.
- R. BHATIA, H. LIN, and R. LAL (2000)
FASEB J
14, 1233-1243
| Abstract »
| Full Text »
- Fresh and nonfibrillar amyloid {beta} protein(1-40) induces rapid cellular degeneration in aged human fibroblasts: evidence for A{beta}P-channel-mediated cellular toxicity.
- Y. J. ZHU, H. LIN, and R. LAL (2000)
FASEB J
14, 1244-1254
| Abstract »
| Full Text »
- The HHQK Domain of beta -Amyloid Provides a Structural Basis for the Immunopathology of Alzheimer's Disease.
- D. Giulian, L. J. Haverkamp, J. Yu, W. Karshin, D. Tom, J. Li, A. Kazanskaia, J. Kirkpatrick, and A. E. Roher (1998)
J. Biol. Chem.
273, 29719-29726
| Abstract »
| Full Text »
| PDF »
- Amyloid beta Protein-(1-42) Forms Calcium-permeable, Zn2+-sensitive Channel.
- S. K. Rhee, A. P. Quist, and R. Lal (1998)
J. Biol. Chem.
273, 13379-13382
| Abstract »
| Full Text »
| PDF »
- Alzheimer's-specific effects of soluble beta -amyloid on protein kinase C-alpha and -gamma degradation in human fibroblasts.
- A. Favit, M. Grimaldi, T. J. Nelson, and D. L. Alkon (1998)
PNAS
95, 5562-5567
| Abstract »
| Full Text »
| PDF »
- Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease.
- L. Gasparini, M. Racchi, G. Binetti, M. Trabucchi, S. B. Solerte, D. Alkon, R. Etcheberrigaray, G. Gibson, J. Blass, R. Paoletti, et al. (1998)
FASEB J
12, 17-34
| Abstract »
| Full Text »
- Secondary Structure and Ca2+-induced Conformational Change of Calexcitin, a Learning-associated Protein.
- G. A. Ascoli, K. X. Luu, J. L. Olds, T. J. Nelson, P. A. Gusev, C. Bertucci, E. Bramanti, A. Raffaelli, P. Salvadori, and D. L. Alkon (1997)
J. Biol. Chem.
272, 24771-24779
| Abstract »
| Full Text »
| PDF »
- Impaired Calcium Regulation in Subcortical Vascular Encephalopathy.
- A. Eckert, M. Oster, H. Forstl, M. Hennerici, and W. E. Muller (1997)
Stroke
28, 1351-1356
| Abstract »
| Full Text »
- Calexcitin: A signaling protein that binds calcium and GTP, inhibits potassium channels, and enhances membrane excitability.
- T. J. Nelson, S. Cavallaro, C.-L. Yi, D. McPhie, B. G. Schreurs, P. A. Gusev, A. Favit, O. Zohar, J. Kim, S. Beushausen, et al. (1996)
PNAS
93, 13808-13813
| Abstract »
| Full Text »
| PDF »
|
|